Injecting a redesigned immunotherapy drug directly into a cancer tumor triggered response in metastatic tumors
Patients with a variety of solid tumors saw cancerous tumors that a had spread to other parts of their bodies shrink when the primary tumor was injected with a re-engineered antibody immunotherapy.
Cancer treatments failing to consider older patients' preferences
A new large-scale analysis of older adults with advanced cancer reveals a stark "preference gap" in modern oncology, showing that clinical treatments rarely align with what patients actually value most.
Palliative care access still limited for advanced cancer patients
A new study analyzing Medicare beneficiaries who died from poor-prognosis cancers between 2018 and 2023 reveals that while specialty palliative care use is increasing, it remains low, particularly among disadvantaged groups.
Cancer linked to obesity tripled in the U.S. over past 20 years
Deaths from obesity-linked cancers have tripled in two decades – Photo credit Unsplash Media CANCER DIGEST – July 20, 2025 – Cancers...
Low-risk thyroid cancer patients can safely forgo radioactive iodine treatments
The thyroid uses iodine, a mineral found in some foods and in iodized salt, to help make several hormones that control heart rate, body...
Engineered T cells targeting solid tumors show promising results in early patient trial
The IMA203 treatment uses T cells engineered to target the PRAME peptide, which is almost exclusively produced by solid tumors and not...
